Work

Nephrinuria as a marker of podocyte dysfunction in hypertensive nephropathy: relationship with renal functional reserve and changes during renin–angiotensin system blockade

Year: 2026
Type: article
Abstract: Hypertensive kidney injury is often detected late by conventional markers. Urinary nephrin excretion (nephrinuria) reflects podocyte injury and may help identify renal involvement in essential hypertension. In this prospective, single-centre study, 60 adults with essential hypertension (20 per 2018 ESC/ESH stage, I–III; 20 men, 40 women) were assessed at baseline and after 6 months of antihypertensive treatment based on renin–angiotensin system (RAS) blockade (enalapril, n = 17; azilsartan, n = 43; add-on eplerenone, n = 21). Urinary nephrin, serum TGF-β1, VEGF-A and aldosterone, cystatin C–based eGFR, renal functional reserve (RFR; protein-loading test), 24-h albuminuria, echocardiography and renal Doppler were measured. Stages were compared by Welch’s ANOVA with Games–Howell post-hoc tests and Holm correction. Nephrinuria rose across stages (91.9 ± 8.3, 124.9 ± 9.3 and 164.5 ± 9.7 pg/mL, mean ± SEM; adjusted P < 0.001; all pairwise P ≤ 0.031), while eGFR at stage I remained within the normal range. RFR was lower at stage III than at stage I (12.5 ± 1.6% vs 22.5 ± 3.1%; P = 0.020), and segmental-artery flow velocity declined with stage, whereas VEGF-A showed only a trend. After 6 months, blood pressure fell and nephrinuria was lower at all stages (−32%, −31% and −23% at stages I, II and III), together with reductions in TGF-β1, VEGF-A and aldosterone. Nephrinuria is a candidate biomarker of podocyte injury in hypertension; controlled studies with assay-specific reference ranges are needed to establish its diagnostic value.
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,353
OpenAlex ID: W7225903464
FWCI:
Cites: 22
Cited by:
Related to: 10
Parts: 1